Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CHEMBIO DIAGNOSTICS, INC.

(CEMI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Chembio Diagnostics : Launches Distribution of Third-Party COVID-19 Antigen Test

08/27/2021 | 08:29am EDT


ę MT Newswires 2021
All news about CHEMBIO DIAGNOSTICS, INC.
10/21CHEMBIO DIAGNOSTICS : to Report Third Quarter 2021 Financial Results on November 4, 2021
AQ
10/20BIOPORTO A/S : Names New CFO; Shares Up 6%
MT
10/18CHEMBIO DIAGNOSTICS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
10/18Chembio Diagnostics, Inc. Announces Termination of Employment of Neil A. Goldman as Exe..
CI
10/18Chembio Diagnostics, Inc. Announces Termination of Employment of Neil A. Goldman as Chi..
CI
09/22CHEMBIO DIAGNOSTICS : Announces EUA Submission for DPP Respiratory Antigen Panel
AQ
09/22Chembio Diagnostics, Inc. Announces EUA Submission for DPP Respiratory Antigen Panel
CI
08/27SECTOR UPDATE : Health Care Stocks Gain Premarket Friday
MT
08/27SECTOR UPDATE : Health Care
MT
08/27CHEMBIO DIAGNOSTICS : Launches Distribution of Third-Party COVID-19 Antigen Test
MT
More news
Analyst Recommendations on CHEMBIO DIAGNOSTICS, INC.
More recommendations
Financials (USD)
Sales 2021 40,5 M - -
Net income 2021 -22,6 M - -
Net Debt 2021 - - -
P/E ratio 2021 -2,54x
Yield 2021 -
Capitalization 65,5 M 65,5 M -
Capi. / Sales 2021 1,62x
Capi. / Sales 2022 1,72x
Nbr of Employees 355
Free-Float 93,9%
Chart CHEMBIO DIAGNOSTICS, INC.
Duration : Period :
Chembio Diagnostics, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CHEMBIO DIAGNOSTICS, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Last Close Price 2,29 $
Average target price 8,00 $
Spread / Average Target 249%
EPS Revisions
Managers and Directors
Richard L. Eberly President, Chief Executive Officer & Director
Neil A. Goldman Chief Financial Officer & Executive Vice President
Katherine Lyon Davis Chairman
Javan Esfandiari Chief Science & Technology Officer
Paul Lambotte Vice President-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
CHEMBIO DIAGNOSTICS, INC.-51.79%66
JOHNSON & JOHNSON5.32%436 334
ROCHE HOLDING AG15.84%338 387
NOVO NORDISK A/S60.69%244 467
PFIZER, INC.17.22%244 227
ELI LILLY AND COMPANY47.15%225 231